Illustration of red blood cells moving through clogged artery to indicate cholesterol build up as a result of familial hypercholesterolemia and atherosclerosis, which can be caused by high levels of lipoprotein(a) or Lp(a).

News & Features

Lipoprotein(a) Lowering Draw Between Lilly and Silence

November 19, 2024

Malignant peripheral nerve sheath tumors (MPNST)

News & Features

In “Quantum Leap,” Almost Half of Adults and Children with NF1 Respond to MEK Inhibitor

November 18, 2024

Melanoma cancer cells of human under microscope

News & Features

New Drug Combo Shows Significant Promise in Advanced Melanoma Trial

November 5, 2024

Illustration of a man's torso and arms with his liver highlighted in red to indicate acute liver failure

News & Features

Novo’s Semaglutide Scores in Liver Fibrosis and MASH Trial

November 4, 2024

News & Features

New Immune Cell Has Key Role in Anti-Tumor Immunity

October 30, 2024

Antibody drug conjugated with cytotoxic payload. Synthetic Biology

News & Features

Radiopharma Startup Alpha-9 Nets $175M Series C

October 24, 2024

Informatics

Passkey Therapeutics Launches with Platform to Design Multifunctional Drugs

Jonathan D. Grinstein, PhD

October 22, 2024

Lymphoma cancer cell that can be targeted by CAR T-cell therapy

News & Features

Immunotherapy Plus Chemotherapy: A New Standard of Care for First-Line, Advanced Hodgkin Lymphoma

Alice McCarthy

October 16, 2024

Informatics

How Is Artificial Intelligence Changing the Clinical Trials Landscape?

Larissa Warneck-Silvestrin

October 8, 2024

3d illustration of the human brain with visible blood vessels illustrating Alzheimer's disease and dementia.

News & Features

AviadoBio and Astellas Ink Potential $2.5B+ Deal for Frontotemporal Dementia Candidate

October 8, 2024

123...45 Page 2 of 45

Podcast Series

Behind the Breakthroughs

Join host Jonathan D. Grinstein, PhD, North American Editor for Inside Precision Medicine, as he uncovers the stories behind the pioneers driving the precision medicine revolution.

Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter.

In Conversation with Vanessa Carter and Sue Charles

Multi-Omics: Unlocking the Complexity of the Proteome

5 Key AI Players Leading the Drug Discovery Push

Gene-Edited Pig Kidney Successfully Xenotransplanted in Living Patient at MGH

Stroke Medication Treatment Window Could Be Wider

Drug development (Research and development)

Lipoprotein(a) Lowering Draw Between Lilly and Silence

In “Quantum Leap,” Almost Half of Adults and Children with NF1 Respond to MEK Inhibitor

New Drug Combo Shows Significant Promise in Advanced Melanoma Trial

Novo’s Semaglutide Scores in Liver Fibrosis and MASH Trial

New Immune Cell Has Key Role in Anti-Tumor Immunity

Radiopharma Startup Alpha-9 Nets $175M Series C

Passkey Therapeutics Launches with Platform to Design Multifunctional Drugs

Immunotherapy Plus Chemotherapy: A New Standard of Care for First-Line, Advanced Hodgkin Lymphoma

How Is Artificial Intelligence Changing the Clinical Trials Landscape?

AviadoBio and Astellas Ink Potential $2.5B+ Deal for Frontotemporal Dementia Candidate

Podcast Series

Behind the Breakthroughs

Related Content

New Method Using Antibodies Can Detect Inflammation Biomarkers in the Blood

People over 55 with High Levels of “Good” Cholesterol Have Heightened Glaucoma Risk

In Vivo Gene Therapy with Apolipoprotein Nanoparticles Targets Bone Marrow

Atalanta Raises $97M to Advance Two Neuro-Targeting RNAi Therapies into the Clinic